Roche
Roche moves obesity drug into pivotal trials after mid-stage success
Andrew Joseph covers health, medicine and the biopharmaceutical industry in Europe. You can reach Andrew on Signal at drawqjoseph.71. Roche plans to launch Phase 3 studies of its lead obesity candidate this quarter after reporting Tuesday that the drug led to significant weight loss in a mid-stage trial. The drug, known as CT-388, caused an […]
Paradigm Health, seeking to use AI to enroll clinical trials, partners with Roche
When people talk about using artificial intelligence to transform the way drugs are studied, they often imagine that high-powered computers would replace any need for human experimentation. But one startup, Paradigm Health, raised $253 million based on a different proposition: AI can make the process of setting up clinical trials cheaper, faster and fairer. On […]
Roche suffers another blow as Indian Supreme Court allows sale of generics of its expensive rare disease drug
In a case billed as profiteering against patients, India’s Supreme Court rejected a petition in which Roche sought to stop a generic drugmaker from selling a cheaper version of an expensive rare disease drug. The move comes after a lower court earlier this month upheld a ruling that it would be in the public interest […]